# Treatment of Post-bariatric Hypoglycaemia

> **NCT04836273** · PHASE2 · COMPLETED · sponsor: **Filip Krag Knop** · enrollment: 24 (actual)

## Conditions studied

- Hyperinsulinemic Hypoglycemia
- Postprandial Hypoglycemia

## Interventions

- **DRUG:** Dasiglucagon
- **DEVICE:** HyoPen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04836273
- **Lead sponsor:** Filip Krag Knop
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-20
- **Primary completion:** 2022-05-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836273, "Treatment of Post-bariatric Hypoglycaemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04836273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*